Intellectual property law

GBT - 3D CHIP and MEMORY Patent Will Be Published in Europe

Retrieved on: 
Wednesday, July 21, 2021

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT   Technologies   Inc.   ( OTC PINK: GTCH ) ("GBT” or the “Company”), is pleased to report the upcoming publication of its 3D CHIP and MEMORY patent in Europe on July 28, 2021. The application has been allocated the number 19862631.9 and designates all European Patent Convention (“EPC”) states, as of the Patent Cooperation Treaty (“PCT”) filing date.

Key Points: 
  • SANDIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT or the Company), is pleased to report the upcoming publication of its3D CHIP and MEMORY patent in Europe on July 28, 2021.
  • The application has been allocated the number 19862631.9 and designates all European Patent Convention (EPC) states, as of the Patent Cooperation Treaty (PCT) filing date.
  • The companys 3D microchip patent was filed on March 5, 2019 and was granted as of December 1, 2020 by the United States Patent and Trademark Office (USPTO); U.S. Patent No.
  • The bibliographic data of the above-mentioned Euro-PCT application will be published on28.07.21 in Section 1.1 of the European Patent Bulletin.

ON24 Announces Date for Second Quarter 2021 Earnings Release and Conference Call

Retrieved on: 
Tuesday, July 20, 2021

ON24 (NYSE: ONTF) will release its second quarter 2021 financial results after U.S. markets close on Tuesday, August 10, 2021. ON24 management will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its business and financial performance.

Key Points: 
  • Through interactive webinars, virtual events, and always-on multimedia experiences, ON24 provides a system of engagement, powered by AI, which enables businesses to scale engagement, conversions, and pipeline to drive revenue growth.
  • The ON24 platform supports millions of professionals a month who are totaling billions of engagement minutes per year.
  • ON24 and the ON24 logo are trademarks owned by ON24, Inc., and are registered in the United States Patent and Trademark Office and in other countries.
  • The other referenced trademarks and service marks are also owned by ON24, Inc. and may be registered in some countries.

Kaival Brands (OTCQB: KAVL): Bidi® Vapor Announces Issuance of New U.S. Patents

Retrieved on: 
Tuesday, July 20, 2021

GRANT, Fla., July 20, 2021 /PRNewswire/ -- Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive global distributor of products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), today announced that the United States Patent and Trademark Office ("USPTO") has issued two additional U.S. patents to Bidi Vapor: Patents Nos.

Key Points: 
  • GRANT, Fla., July 20, 2021 /PRNewswire/ -- Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive global distributor of products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), today announced that the United States Patent and Trademark Office ("USPTO") has issued two additional U.S. patents to Bidi Vapor: Patents Nos.
  • "With the issuance of Bidi Vapor's third and fourth patents, Kaival Brands is proud to continue to be the exclusive global distributor of all products manufactured by BidiVapor" adds Eric Mosser, Chief Operating Officer of Kaival Brands.
  • Bidi Vapor's portfolio includes two other U.S. patents issued earlier this year covering the entire Bidi Stick (U.S. Patent No.
  • As a result, Bidi Vapor and the Company are considered under common control and Bidi Vapor is considered a related party.

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041

Retrieved on: 
Tuesday, July 20, 2021

The 358 patent, assigned to Warner-Lambert Company LLC (a subsidiary of Pfizer), expires in 2041.

Key Points: 
  • The 358 patent, assigned to Warner-Lambert Company LLC (a subsidiary of Pfizer), expires in 2041.
  • The 358 patent is a composition of matter patent that covers the polymorphic form of mirdametinib that is currently in clinical development.
  • SpringWorks has exclusive rights to the 358 patent pursuant to an existing worldwide license with Pfizer.
  • We are very pleased that the USPTO has issued this patent, which extends patent protection for mirdametinib into 2041, said Saqib Islam, Chief Executive Officer of SpringWorks.

Namely Scores Four Product and Culture Awards in One Week

Retrieved on: 
Tuesday, July 20, 2021

The rankings are based entirely on employee ratings collected over a 12-month period (June 2020-June 2021).

Key Points: 
  • The rankings are based entirely on employee ratings collected over a 12-month period (June 2020-June 2021).
  • Awardees were selected following a thorough evaluation process that considered product quality, management team caliber, organization culture, and overall company evolution among other factors.
  • Dunivan commented, This was a tremendous week for Namely, and Id like to thank Comparably and The Software Review for acknowledging the work were doing.
  • Note to editors: Trademarks and registered trademarks referenced herein remain the property of their respective owners.

New Omdia report recognizes Genetec as fastest growing access control software provider in the world

Retrieved on: 
Monday, July 19, 2021

The report shows Genetec displacing traditional access control vendors, and claiming the number two position globally (up from 4th in 2019).

Key Points: 
  • The report shows Genetec displacing traditional access control vendors, and claiming the number two position globally (up from 4th in 2019).
  • As a truly open system, Security Center Synergis connects to a large and growing selection of third-party access control devices.
  • For more information about Genetec access control solutions, please go to: https://www.genetec.com/a/access-control-migration
    *rising to #2 position compared to #3 in 2018.
  • Genetec, and the Genetec logo are trademarks of Genetec Inc. and may be registered or pending registration in several jurisdictions.

Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics

Retrieved on: 
Monday, July 19, 2021

The co-founders of Novellus entered into lock-up agreements with respect to 3,377,690 of the shares of Brooklyn common stock issued in the transaction.

Key Points: 
  • The co-founders of Novellus entered into lock-up agreements with respect to 3,377,690 of the shares of Brooklyn common stock issued in the transaction.
  • The contractual lock-ups extend for a period of three years, subject to certain early release provisions based on the Brooklyn stock price.
  • Following the transaction, Brooklyn had approximately $25 million of cash, which Brooklyn projects, based on its current operating plans, will be sufficient to fund operations through the end of 2023.
  • The transaction relieves Brooklyn from its obligation to pay Novellus a set of upfront fees, clinical development milestone fees and post-registration royalties under a license agreement that Brooklyn entered into in April 2021 with Novellus and Factor.

OneKey MLS Officially Registered With USPTO

Retrieved on: 
Monday, July 19, 2021

The proper representation of this trademark is the registered symbol as follows: OneKey MLS.

Key Points: 
  • The proper representation of this trademark is the registered symbol as follows: OneKey MLS.
  • In a fiercely competitive industry, a registered trademark provides exclusive rights and protections for the OneKey MLS brand identity, extending its reach and increasing its visibility.
  • The registered trademark is a prestigious platform upon which OneKey MLS can maximize its growth potential.
  • Jim Speer, CEO OneKey MLS said, "Having a registered trademark is a valuable brand asset.

BMG and SESAC Digital Licensing Expand Partnership for Southeast Asia and Australia/New Zealand, Administered by Mint

Retrieved on: 
Monday, July 19, 2021

BERLIN, HONG KONG and SYDNEY, July 19, 2021 /PRNewswire/ -- SESAC Digital Licensing and BMG have expanded their partnership with new digital licensing deals for BMG's Anglo-American repertoire in Southeast Asia and Australia/New Zealand.

Key Points: 
  • BERLIN, HONG KONG and SYDNEY, July 19, 2021 /PRNewswire/ -- SESAC Digital Licensing and BMG have expanded their partnership with new digital licensing deals for BMG's Anglo-American repertoire in Southeast Asia and Australia/New Zealand.
  • On behalf of BMG, SESAC Digital Licensing will negotiate license agreements with international online service providers and with the leading local online service providers in the respective markets.
  • Mint Digital Services (Mint) is an alliance between the US music rights organization SESAC and Swiss authors' rights society SUISA.
  • BMG COO Ben Katovsky said: "With SESAC and Mint we have found an ideal partner for digital licensing and royalty administration in these rapidly growing regions.

BMG and SESAC Digital Licensing Expand Partnership for Southeast Asia and Australia/New Zealand, Administered by Mint

Retrieved on: 
Monday, July 19, 2021

BERLIN, HONG KONG and SYDNEY, July 19, 2021 /PRNewswire/ -- SESAC Digital Licensing and BMG have expanded their partnership with new digital licensing deals for BMG's Anglo-American repertoire in Southeast Asia and Australia/New Zealand.

Key Points: 
  • BERLIN, HONG KONG and SYDNEY, July 19, 2021 /PRNewswire/ -- SESAC Digital Licensing and BMG have expanded their partnership with new digital licensing deals for BMG's Anglo-American repertoire in Southeast Asia and Australia/New Zealand.
  • On behalf of BMG, SESAC Digital Licensing will negotiate license agreements with international online service providers and with the leading local online service providers in the respective markets.
  • Mint Digital Services (Mint) is an alliance between the US music rights organization SESAC and Swiss authors' rights society SUISA.
  • BMG COO Ben Katovsky said: "With SESAC and Mint we have found an ideal partner for digital licensing and royalty administration in these rapidly growing regions.